You searched for oral corticosteroids

CHEST 2022, News

Switching or Stopping Biologic Therapy in Severe Asthma Yields Worse Outcomes

October 18, 2022

The CLEAR study compared clinical outcomes and health resource usage in patients with severe asthma who continued, switched, or stopped their biologic treatment.

News

Treatment Needs Often Unmet for Generalized Pustular Psoriasis

August 15, 2022

Patients with flares more likely to have inpatient, emergency department visits

News

OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained

July 25, 2022

Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab

News

Tacrolimus May Be an Alternative for First-Line Lupus Nephritis Therapy

April 4, 2022

In a study, the calcineurin inhibitor tacrolimus proved to be noninferior to intravenous cyclophosphamide.

News

Yescarta Labeling Updated to Include Prophylactic Corticosteroid Use

February 1, 2022

The updated labeling is based on results from a safety management cohort from the ZUMA-1 study.

News

Cibinqo Approved for Refractory, Moderate to Severe Atopic Dermatitis

January 18, 2022

The approval was based on data from the phase 3 JADE clinical trial program, which included the JADE MONO-1, JADE MONO-2, and JADE COMPARE trials.

News

Rinvoq Gains FDA Approval for Atopic Dermatitis

January 18, 2022

The approval was based on data from three phase 3 trials that evaluated the efficacy and safety of upadacitinib in patients 12 years of age and older with moderate to severe atopic dermatitis who are candidates for systemic therapy.

News

Zolgensma Labeling Updated With Additional Safety Information

October 27, 2021

Zolgensma is an adeno-associated virus vector-based gene therapy.

News

Dupixent Asthma Indication Expanded to Include Younger Patients

October 22, 2021

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 VOYAGE trial.

CHEST 2021, News

A New Basis for Predicting Future COPD Exacerbations During the Pandemic

October 19, 2021

Research presented at CHEST 2021 assessed an alternative approach to predicting COPD exacerbations during the COVID-19 pandemic.

Active Filters

Your search for oral corticosteroids returned 61 results

Sort Results:

Switching or Stopping Biologic Therapy in Severe Asthma Yields Worse Outcomes

Treatment Needs Often Unmet for Generalized Pustular Psoriasis

OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained

Tacrolimus May Be an Alternative for First-Line Lupus Nephritis Therapy

Yescarta Labeling Updated to Include Prophylactic Corticosteroid Use

Cibinqo Approved for Refractory, Moderate to Severe Atopic Dermatitis

Rinvoq Gains FDA Approval for Atopic Dermatitis

Zolgensma Labeling Updated With Additional Safety Information

Dupixent Asthma Indication Expanded to Include Younger Patients

A New Basis for Predicting Future COPD Exacerbations During the Pandemic